MedTrace Logo

Transcranial Magnetic Stimulation (rTMS) and Autism.

NCT01648868 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 97

Last updated 2025-09-08

No results posted yet for this study

Summary

In this protocol we aim to use rTMS to better characterize STS role in normal and abnormal social cognition. With that purpose, we will measure the effect of inhibitory and excitatory rTMS on the fixation time on social scenes (using eye-tracking methodology) or on the ability to recognize human voice/sounds.

Conditions

Interventions

DEVICE

Transcranial Magnetic Stimulation (rTMS)

Excitatory effects of Transcranial Magnetic Stimulation (rTMS) applied to the STS in patients with autism.

DEVICE

Transcranial Magnetic Stimulation (rTMS)

Inhibitory effects of Transcranial Magnetic Stimulation (rTMS) applied to the STS in healthy controls

Sponsors & Collaborators

  • URC-CIC Paris Descartes Necker Cochin

    collaborator OTHER

  • Assistance Publique - Hôpitaux de Paris

    lead OTHER

Principal Investigators

  • Nathalie BODDAERT, MD, PhD · Necker-Enfants Malades Hospital

  • Monica ZILBOVICIUS, PhD · Institut National de la Santé Et de la Recherche Médicale, France

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
30 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2011-04-06
Primary Completion
2017-09-27
Completion
2019-05-13

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01648868 on ClinicalTrials.gov